| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/22/1997 | EP0754231A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 01/22/1997 | EP0754226A1 Recombinant equine herpesviruses |
| 01/22/1997 | EP0754223A1 Non-pathogenic strains of hiv-1 |
| 01/22/1997 | EP0754193A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure |
| 01/22/1997 | EP0754191A1 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 01/22/1997 | EP0754059A1 Methods and compositions useful for inhibition of angiogenesis |
| 01/22/1997 | EP0754058A1 Wound healing |
| 01/22/1997 | EP0754057A1 COMPOSITIONS AND METHODS FOR VACCINES COMPRISING $g(a)-GALACTOSYL EPITOPES |
| 01/22/1997 | EP0754056A1 Soft agar penetration-defective mutants |
| 01/22/1997 | EP0754055A1 Group a streptococcal polysaccharide immunogenic compositions and methods |
| 01/22/1997 | EP0549581B1 Framework mutated antibodies and their preparation |
| 01/22/1997 | EP0531401B1 Enhancing the association of exogenous peptides with class i mhc molecules on immune system cells |
| 01/22/1997 | EP0502107B1 Type-b rotavirus cultures and uses thereof |
| 01/22/1997 | CN1141060A Haemophilus transferrin receptor genes |
| 01/22/1997 | CN1141000A Vaccine design and production |
| 01/22/1997 | CN1140609A Medicament for nasal administration |
| 01/22/1997 | CN1033866C Recombinant DNA-derived Bordetella toxin subunit analogs |
| 01/22/1997 | CN1033865C Cell-associated glucosyltransferase, antibody thereto, and dental caries prophylactic composition contg. said antibody as effective component |
| 01/21/1997 | US5596081 Antibodies and atp or gtp |
| 01/21/1997 | US5595972 Polypeptides for signals |
| 01/21/1997 | US5595912 Genetic vectors and rna codes |
| 01/21/1997 | US5595901 Method for obtaining protective active and inactive adenylate cyclase from Bordetella parapertussis |
| 01/21/1997 | US5595885 Matrix metalloproteinase inhibitor peptides |
| 01/21/1997 | US5595871 Detection and prevention of mycoplasma hominis infection |
| 01/21/1997 | US5595868 Monoclonal antibodies to hepatitis C virus |
| 01/21/1997 | US5595744 Respiratory disease vaccine for cats |
| 01/21/1997 | US5595740 Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens |
| 01/21/1997 | US5595739 Hepatitis B virus mutants, reagents and methods for detection |
| 01/21/1997 | US5595738 Immunology and antigens for tumor |
| 01/21/1997 | US5595732 Polyethylene-protein conjugates |
| 01/16/1997 | WO1997001640A2 Vaccines against hepatitis c |
| 01/16/1997 | WO1997001638A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
| 01/16/1997 | WO1997001580A1 Multispecific and multivalent antigen-binding polypeptide molecules |
| 01/16/1997 | WO1997001574A1 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3 |
| 01/16/1997 | WO1997001571A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/16/1997 | WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | WO1997001330A1 Novel adjuvant compositions and vaccine formulations comprising same |
| 01/16/1997 | DE19627392A1 Medikament zur Verabreichung durch die Nase Medication to be administered through the nose |
| 01/16/1997 | DE19525784A1 Autoreaktive Peptide aus der humanen Glutamin-Decarboxylase (GAD) Autoreactive peptides from human glutamic acid decarboxylase (GAD) |
| 01/16/1997 | CA2225405A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | CA2224662A1 Isolated nucleic acid molecule which encodes murine tumor rejection antigen precursor smage-3 |
| 01/16/1997 | CA2222456A1 Vaccines against hepatitis c |
| 01/16/1997 | CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | CA2219904A1 Novel adjuvant compositions and vaccine formulations comprising same |
| 01/15/1997 | EP0753582A1 Immunopotentiator and method of manufacturing the same |
| 01/15/1997 | EP0753581A1 Improved recombinant eukaryotic cytoplasmic viruses, method for their production and their use as vaccines |
| 01/15/1997 | EP0753310A1 Legionellosis vaccines and methods for their production |
| 01/15/1997 | EP0753071A1 Cell-targeted lytic pore-forming agents |
| 01/15/1997 | EP0753066A1 Recombinant bcg vaccines |
| 01/15/1997 | EP0753065A1 Antibodies against e-selectin |
| 01/15/1997 | EP0753061A1 Vaccine compositions |
| 01/15/1997 | EP0753015A1 Monoclonal antibodies recognizing tie-receptor and their use |
| 01/15/1997 | EP0753009A1 Malaria peptides |
| 01/15/1997 | EP0753008A1 Peptide vaccines and methods relating thereto |
| 01/15/1997 | EP0753006A1 Vpr AND Vpx PROTEINS OF HIV |
| 01/15/1997 | EP0753005A1 Cytotoxic t-cell lymphocyte ("ctl") activity regulation by class i mhc peptides |
| 01/15/1997 | EP0752888A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR |
| 01/15/1997 | EP0752887A1 Immunodeficiency recombinant poxvirus |
| 01/15/1997 | EP0752886A1 Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes |
| 01/15/1997 | EP0752880A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon |
| 01/15/1997 | EP0752879A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES |
| 01/15/1997 | EP0752876A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 01/15/1997 | EP0752874A1 Enhanced virus-mediated dna transfer |
| 01/15/1997 | EP0752872A1 Nadh oxidase as a target in diagnosis and therapy |
| 01/15/1997 | EP0752870A1 Immunotherapeutic agent and its use |
| 01/15/1997 | EP0752844A1 Human osteoclast-derived cathepsin |
| 01/15/1997 | EP0527753B1 Purification and use of pertactin, a bordetella pertussis outer membrane protein |
| 01/15/1997 | EP0495831B1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 01/15/1997 | EP0491930B1 Primate lentivirus vaccines |
| 01/15/1997 | EP0440742B1 Liposome immunoadjuvants containing il-2 |
| 01/15/1997 | CN1140414A Use of anti-TNF antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels |
| 01/15/1997 | CN1140413A Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 01/15/1997 | CN1140090A Process for preparing human immunodeficiency virus and hepatitis C virus antibody united diagnostic reagent |
| 01/14/1997 | US5594120 Integrin alpha subunit |
| 01/14/1997 | US5594107 Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon |
| 01/14/1997 | US5594100 Epitope for prevention of type I diabetes |
| 01/14/1997 | US5593972 Genetic immunization |
| 01/14/1997 | US5593884 Oncoprotein protein kinase |
| 01/14/1997 | US5593876 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/14/1997 | US5593873 Vaccines |
| 01/14/1997 | US5593861 Dog-mouse heterohybridoma and gene fragment coding for constant region of canine immunoglobulins |
| 01/14/1997 | US5593825 Hepatitis B virus mutants, reagents and methods for detection |
| 01/14/1997 | US5593698 Immunosuppressants |
| 01/14/1997 | US5593697 Single dose vaccination system |
| 01/14/1997 | US5593679 Poultry vaccine against E. coli air sac inflammation and septicaemia |
| 01/14/1997 | US5593677 Antimonoclonal antibodies for leukemia |
| 01/14/1997 | US5593675 Method of producing an anti-D immunoglobulin concentrate and a pharmaceutical preparation |
| 01/14/1997 | US5593673 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
| 01/14/1997 | US5593669 Pesticide, insecticide |
| 01/14/1997 | CA1338841C Monoclonal antibodies specific for human fibrinopeptide a |
| 01/13/1997 | CA2180215A1 Medicament for nasal administration |
| 01/13/1997 | CA2153733A1 Immunogenic oligosaccharide compositions |
| 01/13/1997 | CA2153730A1 Immunostimulating activity of streptococcus pneumoniae serotype 8 oligosaccharides |
| 01/09/1997 | WO1997000963A1 Diagnostic test for equine arteritis virus mediated disease |
| 01/09/1997 | WO1997000956A1 Hypoxia-responsive adhesion molecules, specific antibodies, and their uses |
| 01/09/1997 | WO1997000950A1 New immunoregulatory protein lst-1 |
| 01/09/1997 | WO1997000946A1 Immortalized epithelial tumor cell |
| 01/09/1997 | WO1997000697A1 A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 01/09/1997 | WO1997000696A1 Low pathogenicity prrs live virus vaccines and methods of preparation thereof |